Carbocistein

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Mucolytic, expectorant.

IndicationThis section has been translated automatically.

Expectoration promotion in bronchopulmonary diseases.

Limited indicationThis section has been translated automatically.

Pregnancy, lactation, children < 12 months.

Dosage and method of useThis section has been translated automatically.

3 times 750 mg/day p.o., after improvement of symptoms 4 times 375 mg/day.

Undesirable effectsThis section has been translated automatically.

Allergic reactions, headaches, dizziness, gastrointestinal disturbances.

ContraindicationThis section has been translated automatically.

Hypersensitivity to the active substance, acute gastrointestinal ulcers.

PreparationsThis section has been translated automatically.

Sedotussin muco, Transbronchin

Authors

Last updated on: 29.10.2020